Small Cell Lung Cancer: Results of a Phase II Study of 1,2,4-Triglycidylurazol
May 1986
in “
Cancer Chemotherapy and Pharmacology
”
Studysummary The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer